From August 2013 to December 2016, Barr and colleagues' prospective study (NCT02650778) enrolled patients with BI-RADS 1 or 2 on screening mammography and breast density C or D to undergo supplemental ...
DALLAS, Sept. 17, 2026 /PRNewswire/ -- Ikonopedia, a leader in structured reporting and clinical decision support for breast imaging, today announced the release of Ikonopedia 2026.08.0, featuring ...
Receiving your mammogram results can be an emotional experience. Whether the news is positive or requires further investigation, it’s important to understand what these results mean for your breast ...
A study found that a 6-month follow-up examination was recommended for women found to have BI-RADS 3 lesions after previous recommendations suggested a year follow-up was safely sufficient. A 6-month ...
Proper evaluation of an abnormal mammogram result is important because approximately 90 percent of women with abnormal results do not have breast cancer. Breast lumps also are an evaluation problem ...
The results indicate BI-RADS 3 assessments are significantly more common in baseline versus non-baseline screening breast MRI exams, and BI-RADS 3 lesions on baseline exams have a lower cancer yield.
Leesburg, VA, July 15, 2021--According to ARRS' American Journal of Roentgenology (AJR), return to routine screening for BI-RADS 3 lesions on supplemental automated whole-breast US (ABUS) ...